FILTER
FILTERED INTERVIEW RESULTS
Wu Yifang
CEO, FOSUN PHARMA
Fosun Pharma is a leading pharma company in China with innovative and global ambitions.
Dr. Jim Li
CEO, SUNDIA
Sundia is a CRO based in China and speaks to GBR of the evolution of the drug discovery process in China.
Dr. Xu Jia
CONSULTING LEADER, PWC CHINA HEALTHCARE AND PHARMACEUTICALS
PwC in China is benefitting from the rise of the biopharma and a flurry of IPO and acquisition activities in the pharma industry more generally.
Jay Dong
GENERAL MANAGER and GLOBAL VP, CST CHINA
CST is expanding its footprint across China where R&D and innovation spending is on the rise.
Jonathan Zhu
PARTNER PRACTICE LEADER, CHINA LIFE SCIENCE & GOVERNMENT AFFAIRS, HEIDRICK & STRUGGLES
H&S is one of the top five recruiting firms globally and is expanding its services in China’s rapidly growing life science sector.
Dr. Wu Xiaobing
COUNTRY MANAGER, PFIZER CHINA & REGIONAL PRESIDENT, PFIZER ESSENTIAL HEALTH GREATER CHINA
Pfizer speaks to GBR about its operations in China.
Ningling Wang
MANAGING PARTNER, FINNEGAN
Finnegan in Shanghai helps Chinese companies protect and enforce their IP in the US and also helps foreign clients with patent litigation in China.
Greg Scott
CEO, CHINABIO CONSULTING
ChinaBio morphed from being an angel investor in China to becoming a consultant for foreign compa-nies looking to enter the Chinese life science space.
Conrad Bucheleres, Wei Hong & Yong Zhang
AZELIS GREATER CHINA
Azelis sources an increasing array of speciality chemicals in China and distributes across the world.
MACIG
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
MINPER 2019 - Guía Oficial de Inversiones de Perumin
PARTNERS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
